Baidu
map

中国呼吸与危重症医学专科医师海外培训项目启动

2017-03-17 谷欣颖 科学网

呼吸系统疾病已成为全球性医疗保健与公共卫生问题,2016年底国家专科医师规范化培训制度试点工作正式启动,呼吸与危重症医学(PCCM)成为首批三个试点专科之一。但在我国,相比心血管、脑血管系统有三级预防体系,呼吸系统疾病的防治有待进一步规范和发展。

呼吸系统疾病已成为全球性医疗保健与公共卫生问题,2016年底国家专科医师规范化培训制度试点工作正式启动,呼吸与危重症医学(PCCM)成为首批三个试点专科之一。但在我国,相比血管、脑血管系统有三级预防体系,呼吸系统疾病的防治有待进一步规范和发展。

中国工程院院士、中国医师协会呼吸医师分会主席、中日医院院长王辰教授3月17日在中华国际医学交流基金会与勃林格殷格翰公司共同在北京举行的“中国PCCM专科医师规范化培训海外交流项目捐赠签约仪式”上说:“PCCM专科医师规范化培训工作是我国呼吸学科的‘基因改造工程’,目的在于培养呼吸与危重症医学的‘种子选手’,对我国呼吸学科的持续发展具有重要意义。”

呼吸与危重症医学涉及支气管哮喘、慢性阻塞性肺疾病、慢性咳嗽等慢性气道疾病,以及呼吸系统感染、肺栓塞与肺血管病、间质性肺疾病、呼吸肿瘤、呼吸衰竭与危重症、呼吸介入等领域。

呼吸与危重症医学专科医师培训起源于上世纪80年代的美国,经过30余年的发展,已成为美国最为主流的呼吸领域及危重症领域专科医师培训模式,欧洲多个国家近年来亦参照美国PCCM专科医师培训模式进行呼吸医师培养。我国呼吸学界自本世纪初即明确提出“呼吸与危重症医学捆绑式发展”战略,其中重要内容之一即为在专科医师培养阶段将呼吸病学与危重症医学有机结合。

王辰院士介绍说:“近年来,呼吸疾病的发病率在我国逐年呈上升趋势,而呼吸疾病的防治并没有得到应有的重视和投入,同时与国际水平尚存在较大差距。此次中国PCCM专科医师规范化培训海外交流项目,通过选拔、资助PCCM专培医师赴美国实地学习美国PCCM培训体系及培训内容,提升专培医师的临床能力,有助进一步促进我国PCCM专培工作与国际接轨,并为未来我国PCCM专培师资队伍建设工作奠定良好基础,是国家PCCM专科医师规范化培训工作的重要补充。”

中国PCCM专科医师规范化培训海外交流项目为期6年,每年将优选全国PCCM专培医师10—15人,前往美国PCCM专培基地医院进行为期三个月的交流与培训,这些医生不仅将学习慢性呼吸疾病的治疗与管理知识,同时将对急、重、危伴有多系统功能紊乱的危重症患者进行管理

作为中国PCCM专科医师规范化培训海外交流项目的发起方,中华国际医学交流基金会特聘王辰院士为该项目专家委员会主任委员。中华国际医学交流基金会自成立以来,始终致力于促进医学公益事业的发展,促进国际医学交流,为我国医疗保健事业和医学现代化服务。此次将公益基金投入到呼吸及危重症医学专科医师培训海外交流项目,将对改变我国整体慢病防治现状,提升大众健康水平起到促进作用。勃林格殷格翰公司大中华区人药业务负责人冯耐德先生表示:“作为一家致力于长期推动中国呼吸学科的发展的企业,我们很高兴能够参与中国PCCM专科医师规范化培训海外交流项目,为促进中国呼吸与危重症医学的发展出力。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-11-23 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-18 蔬菜

    超级棒的项目,只要待遇跟得上

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-18 飛歌

    很不错哦的赞一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-17 1ddf0692m34(暂无匿称)

    好项目,值得推行

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-17 Albert Wu

    该项目能促进中国呼吸与危重症医学的发展

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-17 1e15b6fem30(暂无匿称)

    很好的学习资料,谢谢了。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1748907, encodeId=e8031e4890780, content=<a href='/topic/show?id=e4d6655811a' target=_blank style='color:#2F92EE;'>#海外#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65581, encryptionId=e4d6655811a, topicName=海外)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82fd36209189, createdName=lishizhe, createdTime=Thu Nov 23 07:09:00 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715263, encodeId=a84c1e15263b3, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Wed Jul 12 16:09:00 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579609, encodeId=833e15e96094c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun Mar 19 11:09:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180767, encodeId=2da8180e67c7, content=超级棒的项目,只要待遇跟得上, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Sat Mar 18 07:19:51 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180724, encodeId=1d0c180e24c3, content=很不错哦的赞一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Mar 18 00:36:35 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180692, encodeId=0c291806921b, content=好项目,值得推行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Mar 17 23:35:53 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180669, encodeId=ca1d180669f7, content=该项目能促进中国呼吸与危重症医学的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:41:04 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180668, encodeId=f1f6180668a5, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 17 22:40:39 CST 2017, time=2017-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180667, encodeId=369418066ecb, content=这项目挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd301464769, createdName=Albert Wu, createdTime=Fri Mar 17 22:40:13 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-17 Albert Wu

    这项目挺好

    0

相关资讯

不是基因的错,越长越丑,可能是呼吸的方式阻碍你的美!

读这篇文章之前,先回答我两个问题。你现在专心致志看手机的这个时刻,嘴是微张着还是闭着?你在放松的时候,舌头放在哪里?如果你的答案不是“闭着”和“紧贴在我的上颚”,那你可能会想继续看下去。我们身边是否有这么几个人,他们的表情总像这样:告诉我,凭直觉,你觉得下图的男生,眼神中散发着智慧的光芒吗?他们闭上嘴拍照,你就答应跟他约会了?英国有一对同胞姐妹,七岁的妹妹Kelly(左)和八岁半的Samantha

ISRD & ATS 2016:专访白春学教授——物联网医学助力中国呼吸病学发展

美国胸科学会(ATS)携手上海市呼吸病研究所联合举办的第十二届国际呼吸学会暨ATS联合论坛(ISRD & ATS 2016)于今日在中国上海展览中心(上海市中心静安区延安中路1000号)隆重召开。作为本届大会的承办单位,梅斯医学也参与了这场呼吸学界的盛会。在今天上午的大会现场,梅斯医学小编有幸采访到了本届大会主席——中国肺癌防治联盟主席、上海市呼吸病研究所所长、复旦大学附属中山医院呼吸科主

JAMA SURGERY:减肥手术后是否需要常规使用IS

肥胖和前肠手术的组合使患者接受减肥手术后存在肺部并发症的高风险。术后诱发性肺量测定法(IS)是一种普遍存在的做法;然而,对其有效性几乎目前尚没有足够的证据。近期一项发表在JAMA SURGERY杂志上的文章研究了术后IS对低氧血症、动脉血氧饱和度(Sao2)水平和减肥手术后的肺部并发症的影响。研究采用随机临床试验纳入2015年5月1日至2016年6月30日接受减肥手术的患者。患者在单中心三级转诊教

失眠终结术!美国医生创立60秒极速入睡法

现代人生活压力大,继而产生失眠等症状,美国一名医生为此发明“4-7-8“呼吸法,宣称能帮助人们60秒内进入睡眠。 美国亚利桑那州一位医生安德鲁.威尔博士推广一种帮助睡眠的4-7-8呼吸方法,称为“神经系统天然的镇静剂”,可以在60秒内进入睡眠,而不用药物,而且该方法可以减轻焦虑,有益于心理健康。哈佛大学毕业的医生韦尔近期发表“4-7-8”呼吸法,能使人在60秒内进入睡眠状态。放心,失眠的痛苦我们懂

J Neurosci:新鲜了!呼吸可影响机体的记忆能力

没有呼吸人不可能生存,呼吸可为细胞提供所需的氧气。但是,近期来自西北大学费因伯格医学院的一项新的研究发现呼吸还可影响记忆,并可调节我们对恐惧的反应,该研究结果已发表于Neuroscience。通过分析7名癫痫患者,研究人员首次揭示了呼吸和大脑活动之间的关联。患者接受脑手术前一周在其大脑中植入电极以测量其大脑的活动,确定患者癫痫发作的来源。结果发现,患者的大脑活动随着呼吸而改变,特别是在涉及处理气味

一部吸入治疗史,道尽古今生死事

又到了每年和雾霾天气斗争的时期,寻常的呼吸,受到了来自环境污染的威胁。而对于患有呼吸系统疾病的人而言,一呼一吸,更是在和死神较量。庆幸的是,人类在呼吸疾病面前永远没有停止探索的脚步,开发出种种吸入治疗的方法。几千年前的古埃及人通过吸入莨菪烟雾来治疗呼吸困难,由此拉开吸入疗法的序幕。谁又能想到,如今的呼吸疾病患者,只需随手携带一个小巧的装置,便可对抗可怕的疾病。一部吸入治疗史,就是和死神斗争的历

Baidu
map
Baidu
map
Baidu
map